Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
13F holders, Q1 2026
Institutional positions in Medicus Pharma Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q4 2025
- Shares held
- 2.32M
- −1.62M (−41.1%) vs. Q4 2025
- Total value
- $301.6K
- −$5.73M (−95.0%) vs. Q4 2025
- New holders
- 7
- 6 more added
- Sold out
- 7
- 3 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.18M |
| Q1 2026 | 21 | $301.6K |
| Q4 2025 | 21 | $6.03M |
| Q3 2025 | 20 | $4.91M |
| Q2 2025 | 21 | $6.60M |
| Q1 2025 | 7 | $11.4M |
| Q4 2024 | 3 | $3.74M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Medicus Pharma Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Private Advisor Group, LLC | 240,055 | $110.2K | 0.00% | +64,560+36.8% | Added |
| Virtu Financial LLC | 74,045 | $34.0K | 0.00% | +74,045 | New |
| Bryn Mawr Trust Co | 51,244 | $23.5K | 0.00% | 00.0% | Unchanged |
| May Hill Capital, LLC | 50,622 | $23.2K | 0.01% | +15,000+42.1% | Added |
| Commonwealth Equity Services, LLC | 48,143 | $22.1K | 0.00% | +19,650+69.0% | Added |
| UBS Group AG | 40,441 | $18.6K | 0.00% | +27,210+205.7% | Added |
| BlackRock, Inc. | 37,294 | $17.1K | 0.00% | +2,977+8.7% | Added |
| Citadel Advisors LLC | 17,824 | $8.18K | 0.00% | +17,824 | New |
| Two Sigma Securities, LLC | 15,617 | $7.17K | 0.00% | +15,617 | New |
| LPL Financial LLC | 15,612 | $7.17K | 0.00% | +15,612 | New |
| Marathon Capital Management | 15,500 | $7.12K | 0.00% | +15,500 | New |
| StoneX Group Inc. | 15,169 | $6.96K | 0.00% | +15,169 | New |
| Smithfield Trust Co | 11,480 | $5.00K | 0.00% | −2,403−17.3% | Reduced |
| Brave Asset Management Inc | 10,000 | $4.56K | 0.00% | −10,000−50.0% | Reduced |
| Advisor Group Holdings, Inc. | 8,500 | $3.91K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,468 | $2.51K | 0.00% | −12,838−70.1% | Reduced |
| Jones Financial Companies LLLP | 400 | $180 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 121 | $56 | 0.00% | +121 | New |
| Wells Fargo & Company | 75 | $34 | 0.00% | 00.0% | Unchanged |
| Hazlett, Burt & Watson, Inc. | 425 | $0 | 0.00% | 00.0% | Unchanged |
| Interchange Capital Partners, LLC | 1,661,871 | – | – | +75,000+4.7% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,810,960−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −60,337−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −40,162−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,529−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,319−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| DAGCO, Inc. | 0 | $0 | 0.00% | −349−100.0% | Sold out |